141 related articles for article (PubMed ID: 15261304)
21. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological profile of progestins.
Sitruk-Ware R
Maturitas; 2004 Apr; 47(4):277-83. PubMed ID: 15063480
[TBL] [Abstract][Full Text] [Related]
23. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C
Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938
[TBL] [Abstract][Full Text] [Related]
24. Effect of norethisterone and its A-ring reduced metabolites on the acrosome reaction in porcine spermatozoa.
Martinez G; Zayas H; Ducolomb Y; Garcia GA; Betancourt M; Castro I
Andrologia; 2002 Oct; 34(5):296-300. PubMed ID: 12390087
[TBL] [Abstract][Full Text] [Related]
25. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a rapid in vitro androgen receptor transcriptional activation assay using AR-EcoScreen cells.
Araki N; Ohno K; Takeyoshi M; Iida M
Toxicol In Vitro; 2005 Apr; 19(3):335-52. PubMed ID: 15713541
[TBL] [Abstract][Full Text] [Related]
27. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
28. Valproate is an anti-androgen and anti-progestin.
Death AK; McGrath KC; Handelsman DJ
Steroids; 2005 Dec; 70(14):946-53. PubMed ID: 16165177
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro.
Xu LC; Liu L; Ren XM; Zhang MR; Cong N; Xu AQ; Shao JH
Toxicology; 2008 Jan; 243(1-2):59-65. PubMed ID: 17980950
[TBL] [Abstract][Full Text] [Related]
30. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
[TBL] [Abstract][Full Text] [Related]
31. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
[TBL] [Abstract][Full Text] [Related]
32. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
33. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
34. Detection of anabolic steroid abuse using a yeast transactivation system.
Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
[TBL] [Abstract][Full Text] [Related]
35. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.
Vivat V; Gofflo D; Garcia T; Wurtz JM; Bourguet W; Philibert D; Gronemeyer H
J Mol Endocrinol; 1997 Apr; 18(2):147-60. PubMed ID: 9134501
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
37. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
[TBL] [Abstract][Full Text] [Related]
38. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
[TBL] [Abstract][Full Text] [Related]
39. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
40. 7alpha-methyl-19-nortestosterone, a synthetic androgen with high potency: structure-activity comparisons with other androgens.
Kumar N; Crozat A; Li F; Catterall JF; Bardin CW; Sundaram K
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):213-22. PubMed ID: 10704910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
